$ARX Balance Sheet | Understand Stock

$ARX

$19.82 +$0.05 (0.25%) Close

$ARX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025
Assets
Investments
Available for sale investments, at fair value
Short-term investments
Short-term investments
Fixed maturity securities
Total available for sale investments, at fair value
Equity method investments
Other investments
Total investments
Cash, cash equivalents and restricted cash
Premiums receivable (net of allowance 2026: $5.1 and 2025: $4.6)
Ceded unearned premiums
Reinsurance recoverables on unpaid losses and LAE
Other reinsurance recoverables
Deferred acquisition costs
Goodwill and other intangible assets, net
Capitalized technology development costs, net
Other assets
Total assets
Liabilities and shareholders' equity
Unpaid losses and loss adjustment expenses
Unearned premiums
Payables to reinsurers
Deferred ceding commissions
Funds held under reinsurance
Insurance balances payable
Debt
Accounts payable and other liabilities
Total liabilities
Equity
Class C convertible preference shares (issued and outstanding 2024: 5,556,546)
Shareholders' equity
Convertible preference shares
Class A convertible preference shares
Class B convertible preference shares
Common shares (par value $0.000001 per share, issued and outstanding 2026: Class A - 118,278,172; Class B - 98,639,873 and 2025: Class A - 114,580,918; Class B - 107,241,428)
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total Accelerant shareholders' equity
Non-controlling interests
Total equity
Total liabilities and equity

Comments